Yale School of Medicine: Trial Results Provide Insights Into TAVR For Aortic Stenosis
December 16, 2023
December 16, 2023
NEW HAVEN, Connecticut, Dec. 16 (TNSres) -- The Yale University School of Medicine issued the following news:
John Forrest, MD, FACC, FSCAI, associate professor of medicine (cardiovascular medicine), recently shared four-year outcome results from the Evolut Low Risk Trial at the TCT (Transcatheter Cardiovascular Therapeutics) Conference. The study, which was simultaneously published in the Journal of the American College of Cardiology (JACC), compares two approaches to treating seve . . .
John Forrest, MD, FACC, FSCAI, associate professor of medicine (cardiovascular medicine), recently shared four-year outcome results from the Evolut Low Risk Trial at the TCT (Transcatheter Cardiovascular Therapeutics) Conference. The study, which was simultaneously published in the Journal of the American College of Cardiology (JACC), compares two approaches to treating seve . . .